Canada markets open in 7 hours 59 minutes

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4919+0.0209 (+4.44%)
At close: 04:00PM EDT
0.4640 -0.03 (-5.67%)
After hours: 05:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.35M
Enterprise Value -1.91M
Trailing P/E 1.80
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.64
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.52

Trading Information

Stock Price History

Beta (5Y Monthly) 0.98
52-Week Change 3-67.20%
S&P500 52-Week Change 327.84%
52 Week High 31.8690
52 Week Low 30.4300
50-Day Moving Average 30.5136
200-Day Moving Average 30.6469

Share Statistics

Avg Vol (3 month) 3111.6k
Avg Vol (10 day) 325.59k
Shares Outstanding 54.78M
Implied Shares Outstanding 64.78M
Float 83.59M
% Held by Insiders 16.08%
% Held by Institutions 14.90%
Shares Short (Apr 30, 2024) 473.62k
Short Ratio (Apr 30, 2024) 41.99
Short % of Float (Apr 30, 2024) 41.57%
Short % of Shares Outstanding (Apr 30, 2024) 41.54%
Shares Short (prior month Mar 28, 2024) 4268.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 22, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Oct 17, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-75.90%
Return on Equity (ttm)-160.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.88M
Net Income Avi to Common (ttm)-12.54M
Diluted EPS (ttm)-3.8400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.9M
Total Cash Per Share (mrq)1.37
Total Debt (mrq)289.64k
Total Debt/Equity (mrq)5.48%
Current Ratio (mrq)5.02
Book Value Per Share (mrq)1.34

Cash Flow Statement

Operating Cash Flow (ttm)-12.85M
Levered Free Cash Flow (ttm)-8.99M